Q&A With Jeffrey Cohen From Cleveland Clinic: ECTRIMS Provides Global View of Multiple Sclerosis Today And In the Future

The ECTRIMS conference may be based in Europe but as the conference has grown so has its global impact on multiple sclerosis treatment. With topics ranging from newly approved therapies to those in the pipeline to those not yet ready for testing there is lots to learn in the yearly event.

Jeffrey Cohen, MD from Cleveland Clinic was part of a large contingent of American doctors to make the trip to Barcelona and said there were many things that he and his colleagues could bring back to their practice to help their patients in the near and distant future.